Global tissue demand grew again in August, EMGE reports in its latest tissue highlights, even though apparent demand fell clearly in both Western Europe and North America. The growth came from what EMGE calls Big Asia, and above all from China, where mills are turning out high volumes from new capacity started up over the past year or so.
That extra output is pushing operating ratios down in the region. Most of EMGE’s sources say Chinese prices are stable or falling, which EMGE says makes sense as sellers try to find a home for the additional volume in a sector where real, underlying demand usually changes only a little over time.
The drop in North America has a simple explanation. Demand ran above trend in July, just ahead of price rises, then eased back in August as buyers began to use up those extra purchases. EMGE calls that absolutely normal.
Western Europe is harder to read. There were no price rises there, and while the region is struggling with high fuel costs and inflation, EMGE notes those did not suddenly become a factor in the summer. It says it will keep monitoring the situation.
On a three-month moving average basis, August tissue operating ratios were 77% in Western Europe, 84% in North America, 66% in China, Japan and Korea, and 70% in the rest of the world.
Read the full paper tissue market analysis here.


